ADDICTIONS CAG PUBLICATIONS 2016
Agrawal A. Grant J.D. Lynskey M.T. Madden P.A. Heath A.C. Bucholz K.K. Sartor C.E. (2016). The genetic relationship between cannabis and tobacco cigarette use in European- and African-American female twins and siblings. Drug and Alcohol Dependence. 163:165-171. doi: 10.1016/j.drugalcdep.2016.04.011.
Agrawal A. Few L. Nelson E.C. Deutsch A. Grant J.D. Bucholz K.K. Madden P.A. Heath A.C. Lynskey M.T. (2016). Adolescent cannabis use and repeated voluntary unprotected sex in women. Addiction. doi: 10.1111/add.13490. [Epub ahead of print].
Ali K. Rosser T. Bhat R. Wolff K. Hannam S. Rafferty GF. Greenough A. (2016). Antenatal smoking and substance-misuse, infant and newborn response to hypoxia. Pediatric Pulmonology. doi: 10.1002/ppul.23620. [Epub ahead of print].
Ali K. Rossor T. Bhat R. Wolff K. Hannam S. Rafferty G.F. Greenough A. (2016). Ventilatory responses to hypercarbia in infants of mothers who smoke and misuse substances. Journal of Pediatrics.175:224-227. doi: 10.1016/j.jpeds.2016.04.078.
Alqurshi A. A. M. Kumar Z. McDonald R. S. Strang J. S. Buanz A. Ahmed S. Allen E. Cameron P. Rickard J. Sandhu V. Holt C. Stansfield R. Taylor D. M. Forbes B. J. Royall P. G. (2016). Amorphous formulation and in vitro performance testing of instantly disintegrating buccal tablets for the emergency delivery of naloxone. Molecular Pharmaceutics. 13(5):1688–1698. doi: 10.1021/acs.molpharmaceut.6b00096.
Anderson P. Bendtsen P. Spak F. Reynolds J. Drummond C. Segura L. Keurhorst M.N. Palacio-Vieira J. Wojnar M. Parkinson K. Colom J. Kłoda K. Deluca P. Baena B. Newbury-Birch D. Wallace P. Heinen M. Wolstenholme A. van Steenkiste B. Mierzecki A. Kozaryn K.O. Ronda G. Kaner E. Laurant M.G. Coulton S. Gual T. (2016). Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trial. Addiction. doi: 10.1111/add.13476. [Epub ahead of print].
Barratt M.J. Ferris J.A. Winstock A.R. (2016). Safer scoring? Cryptomarkets, social supply and drug market violence. International Journal of Drug Policy. 35:24-31. doi: 10.1016/j.drugpo.2016.04.019.
Bauld L. MacKintosh A.M. Ford A. McNeill A. (2016). E-cigarette uptake amongst UK youth: experimentation, but little or no regular use in nonsmokers. Nicotine and Tobacco Research. 18(1):102-103. doi: 10.1093/ntr/ntv132
Bauld L. McNeill A. Hajek P. Britton J. Dockrell M. (2016). E-cigarette use in public places: striking the right balance. Tobacco Control. doi: 10.1136/tobaccocontrol-2016-053357. [Epub ahead of print].
Beattie A. Marques E.M. Barber M. Greenwood R. Ingram J. Ayres R. Neale J. Rees A. Coleman B. Hickman M. (2016). Script in a Day intervention for individuals who are injecting opioids: a feasibility randomized control trial. Journal of Public Health. 38(4):712-721. doi: 10.1093/pubmed/fdv161
Bianconi F. Bonomo M. Marconi A. Kolliakou A. Stilo S. A. Iyegbe C. Gurillo Muñoz P. Homayoun S. Mondelli V. Luzi S. Dazzan P. Prata D. La Cascia C. O'Connor J. David A. Morgan C. Murray R. M. Lynskey M. Di Forti M. (2016). Differences in cannabis-related experiences between patients with a first episode of psychosis and controls. Psychological Medicine. 46(5):995-1003. doi: 10.1017/S0033291715002494.
Bogdanowicz K.M. Stewart R. Chang C.K. Downs J. Khondoker M. Shetty H. Strang J. Hayes R.D. (2016). Identifying mortality risks in patients with opioid use disorder using brief screening assessment: Secondary mental health clinical records analysis. Drug and Alcohol Dependence. 164:82-88. doi: 10.1016/j.drugalcdep.2016.04.036
Breindahl T. Kimergård A. Andreasen M.F. Pedersen D.S. (2016). Identification of a new psychoactive substance in seized material: The synthetic opioid N-phenyl-N-[1-(2-phenethyl) piperidin-4-yl]prop-2-enamide (Acrylfentanyl). Drug Testing and Analysis. doi: 10.1002/dta.2046. [Epub ahead of print].
Britton J. Arnott D. McNeill A. Hopkinson N. Tobacco Advisory Group of the Royal College of Physicians. (2016). Nicotine without smoke-putting electronic cigarettes in context. BMJ. 353:i1745. doi: 10.1136/bmj.i1745.
Brose L.S. McEwen A. (2016). Neighbourhood deprivation and outcomes of stop smoking support - an observational study. PLoS One. 11(1):e0148194. doi: 10.1371/journal.pone.0148194.
Brose L.S. Hitchman S.C. Brown J. West R. McNeill A. (2016). Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 110(7):1160-1168. doi: 10.1111/add.12917.
Brose L.S. Partos T.R. Hitchman S.C. McNeill A. (2016). Support for e-cigarette policies: a survey of smokers and ex-smokers in Great Britain. Tobacco Control. doi: 10.1136/tobaccocontrol-2016-052987. [Epub ahead of print].
Brown J. West R. Angus C. Beard E. Brennan A. Drummond C. Hickman M. Holmes J. Kaner E. Michie S. (2016). Comparison of brief interventions in primary care on smoking and excessive alcohol consumption: a population survey in England. British Journal of General Practice. 66(642):e1-9. doi: 10.3399/bjgp16X683149
Brown J. West R. Beard E. Brennan A. Drummond C. Gillespie D. Hickman M. Holmes J. Kaner E. Michie S. (2016). Are recent attempts to quit smoking associated with reduced drinking in England? A cross-sectional population survey. BMC Public Health. 16:535. doi: 10.1186/s12889-016-3223-6
Campbell G. Bruno R. Lintzeris N. Cohen M. Nielsen S. Hall W. Larance B. Mattick R.P. Blyth F. Farrell M. Degenhardt L. (2016). Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients? Pain. 157(7):1489-1498. doi: 10.1097/j.pain.0000000000000548.
Capon H. Hall W. Fry C. Carter A. (2016). Realising the technological promise of smartphones in addiction research and treatment: An ethical review. International Journal of Drug Policy. 36:47-57. doi: 10.1016/j.drugpo.2016.05.013.
Carey C.E. Agrawal A. Bucholz K.K. Hartz S.M. Lynskey M.T. Nelson E.C. Bierut L.J. Bogdan R. (2016). Associations between polygenic risk for psychiatric disorders and substance involvement. Frontiers in Genetics. 7. doi: 10.3389/fgene.2016.00149.
Carter A. Hendrikse J. Lee N. Yücel M. Verdejo-Garcia A. Andrews Z. Hall W. (2016). The neurobiology of "Food Addiction" and its implications for obesity treatment and policy. Annual Review of Nutrition. 36. doi: 10.1146/annurev-nutr-071715-050909. [Epub ahead of print].
Chan G.C. Kelly A.B. Connor J.P. Hall W. D. Young R.M. Williams J.W. (2016). Does parental monitoring and disapproval explain variations in alcohol use among adolescents from different countries of birth? Drug and Alcohol Review. doi: 10.1111/dar.12413. [Epub ahead of print].
Chan G.C. Leung J. Quinn C. Kelly A.B. Connor J.P. Weier M. Hall W.D. (2016). Rural and urban differences in adolescent alcohol use, alcohol supply, and parental drinking. Journal of Rural Health. 32(3):280-286. doi: 10.1111/jrh.12151.
Connor J.P. Haber P.S. Hall W.D. (2016). Alcohol use disorders. Lancet. 387(10022):988-998. doi: 10.1016/S0140-6736(15)00122-1.
Copello A. Mahmood M. Day E. (2016). Alcohol and Other Drug Problems. In Carr A. & McNulty M. (eds) The Handbook of Adult Clinical Psychology: An Evidence Based Approach. London: Routledge. ISBN-13: 978-1583918548
Courtney R.J. Clare P. Boland V. Martire K.A. Bonevski B. Hall W. Siahpush M. Borland R. Doran C.M. West R. Farrell M. Mattick R.P. (2016). Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers. Addictive Behaviors. 64:13-20. doi: 10.1016/j.addbeh.2016.07.019.
Day E. Jheeta M. (2016). Management of Alcohol Use Disorders in the UK. In Mistral W. (ed.) Integrated Approaches to Drug and Alcohol Problems: Action on addiction. London: Routledge. ISBN-13: 978-1138854376
Degenhardt L. Stockings E. Patton G. Hall W. D. Lynskey M. (2016). The increasing global health priority of substance use in young people.The Lancet Psychiatry. 3(3):251–264. doi: 10.1016/S2215-0366(15)00508-8
Degenhardt L. Stockings E. Strang J. Marsden J. Hall W.D. (2016). Illicit Drug Dependence. In: Patel V. Chisholm D. Dua T. Laxminarayan R. Medina-Mora M.E. eds. Mental, Neurological and Substance Use Disorders: Disease Control Priorities. Third Edition. Chapter 6. Washington (DC): The International Bank for Reconstruction and Development / The World Bank. doi: 10.1596/978-1-4648-0426-7_ch6
Degenhardt L. Sara G. McKetin R. Roxburgh A. Dobbins T. Farrell M. Burns L. Hall W.D. (2016). Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review. doi: 10.1111/dar.12426. [Epub ahead of print].
Degenhardt L. Charlson F. Stanaway J. Larney S. Alexander L.T. Hickman M. Cowie B. Hall W.D. Strang J. Whiteford H. Vos T. (2016). Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infectious Diseases. doi: 10.1016/S1473-3099(16)30325-5. [Epub ahead of print].
Demant D. Hides L. Kavanagh D.J. White K.M. Winstock A.R. Ferris J. (2016). Differences in substance use between sexual orientations in a multi-country sample: findings from the Global Drug Survey 2015. Journal of Public Health. doi: 10.1093/pubmed/fdw069. [Epub ahead of print].
Deutsch A.R. Slutske W.S. Lynskey M.T. Bucholz K.K. Madden P.A. Heath A.C. Martin N.G. (2016). From alcohol initiation to tolerance to problems: Discordant twin modeling of a developmental process. Developments in Psychopathology. 15:1-17. doi: 10.1017/S0954579416000523. [Epub ahead of print].
Dimber R. Guo Q. Bishop C. Adonis A. Buckley A. Kocsis A. Owen D. Kalk N. Newbould R. Gunn R. Rabiner E. Taylor G.P. (2016). Evidence of brain inflammation in patients with Human T Lymphotropic Virus type 1 associated myelopathy (HAM): A pilot multi modal imaging study using [11C] PBR28 PET, MR T1w and DWI. Journal of Nuclear Medicine. doi: 10.2967/jnumed.116.175083. [Epub ahead of print]
Donoghue K. Rose A. Coulton S. Milward J. Reed K. Drummond C. Little H. (2016). Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol. BMC Psychiatry. 16:40. doi: 10.1186/s12888-016-0757-1.
Drummond C. Gilburt H. Burns T. Copello A. Crawford M. Day E. Deluca P. Godfrey C. Parrott S. Rose A. Sinclair J. Coulton S. (2016). Assertive Community Treatment for people with alcohol dependence: A pilot randomized controlled trial. Alcohol and Alcoholism. doi: 10.1093/alcalc/agw091. [Epub ahead of print].
Englund A. Atakan Z. Kralj A. Tunstall N. Murray R. Morrison P. (2016). The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial. Journal of Psychopharmacology. 30(2):140-151. doi: 10.1177/0269881115615104.
Few L.R. Grant J.D. Nelson E.C. Trull T.J. Grucza R.A. Bucholz K.K. Verweij K.J. Martin N.G. Statham D.J. Madden P.A. Heath A.C. Lynskey M.T. Agrawal A. (2016). Cannabis involvement and nonsuicidal self-injury: A discordant twin approach. Journal of Studies on Alcohol and Drugs. 77(6):873-880. doi: 10.15288/jsad.2016.77.873.
Foley M. Breindahl T. Hindersson P. Deluca P. Kimergård A. (2016). Misuse of 'over-the-counter' codeine analgesics: does formulation play a role? Public Health. 130:95-96. doi: 10.1016/j.puhe.2015.10.006.
Foley M. Carney T. Rich E. Parry C. Van Hout M.C. Deluca P. (2016). Medical professionals' perspectives on prescribed and over-the-counter medicines containing codeine: a cross-sectional study. BMJ Open. 6(7):e011725. doi: http://bmjopen.bmj.com/content/6/7/e011725.
Gartner C. Hall W. (2016). Assessing the place of nicotine vaporisers in tobacco control. Tobacco Control. 25:e1-2. doi: 10.1136/tobaccocontrol-2016-053025.
Gilchrist G. Radcliffe P. Noto A.R. d'Oliveira A.F.P.L. (2016). The prevalence and factors associated with ever perpetrating intimate partner violence by men receiving substance use treatment in Brazil and England: a cross-cultural comparison. Drug and Alcohol Review. doi: 10.1111/dar.12436. [Epub ahead of print].
Gilchrist G. Tirado Munoz J. Taylor A. Fischer G. Moskalewicz J. Di Furia L. Köchl B. Giammarchi C. Dąbrowska K. Shaw A. Munro A. Torrens M. (2016). An uncontrolled, feasibility study of a group intervention to reduce hepatitis C transmission risk behaviours and increase transmission knowledge among women who inject drugs. Drugs: Education, Prevention and Policy. doi: 10.1080/09687637.2016.1197885. [Epub ahead of print].
Giles E.L. Coulton S. Deluca P. Drummond C. Howel D. Kaner E. McColl E. McGovern R. Scott S. Stamp E. Sumnall H. Tate L. Todd L. Vale L. Albani V. Boniface S. Ferguson J. Frankham J. Gilvarry E. Hendrie N. Howe N. McGeechan G.J. Stanley G. Newbury-Birch D. (2016). Multicentre individual randomised controlled trial of screening and brief alcohol intervention to prevent risky drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH): study protocol. BMJ Open. 6(12):e012474. doi: 10.1136/bmjopen-2016-012474.
Hall W.D. (2016). Commentary on Imtiaz et al. (2016): The burden of disease attributable to cannabis-implications for policy. Addiction. 111(4):663-664. doi: 10.1111/add.13272.
Hall W.D. Chan G. (2016). Commentary on Ogeil et al. (2016): Explaining increased alcohol-related harm and stable per capita consumption in Australia. Addiction. 111(4):635-636. doi: 10.1111/add.13246.
Hall W. Doran C. (2016). How much can the USA reduce health care costs by reducing smoking? PLoS Medicine. 13(5):e1002021. doi: 10.1371/journal.pmed.1002021.
Hall W. Lynskey M. (2016). Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction. 111(10):1764-1773. doi: 10.1111/add.13428.
Hall W. Lynskey M. (2016). Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. The Lancet Psychiatry. doi: 10.1016/S2215-0366(16)30071-2. [Epub ahead of print].
Hall W. Lynskey M. (2016). Long-term marijuana use and cognitive impairment in middle age. JAMA Internal Medicine. 176(3):362-363. doi: 10.1001/jamainternmed.2015.7850.
Hall W. Weier M. (2016). Lee Robins' studies of heroin use among US Vietnam veterans. Addiction. doi: 10.1111/add.13584. [Epub ahead of print].
Hall W.D. Patton G. Stockings E. Weier M. Lynskey M. Morley K.I. Degenhardt L. (2016). Why young people's substance use matters for global health. Lancet Psychiatry. 3(3):265-279. doi: 10.1016/S2215-0366(16)00013-4.
Heslin M. Lappin J.M. Donoghue K. Lomas B. Reininghaus U. Onyejiaka A. Croudace T. Jones P.B. Murray R.M. Fearon P. Doody G.A. Dazzan P. Craig T.J. Morgan C. (2016). Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients. Schizophrenia Research. 176(2-3):417-422. doi: 10.1016/j.schres.2016.04.049.
Heslin M. Desai R. Lappin J.M. Donoghue K. Lomas B. Reininghaus U. Onyejiaka A. Croudace T. Jones P.B. Murray R.M. Fearon P. Doody G.A. Dazzan P. Fisher H.L. Demjaha A. Craig T. Morgan C. (2016). Biological and psychosocial risk factors for psychotic major depression. Social Psychiatry and Psychiatric Epidemiology. 51:233–245. doi: 10.1007/s00127-015-1131-1.
Hindocha C. Freeman T.P. Winstock A.R. Lynskey M.T. (2016). Vaping cannabis (marijuana) has the potential to reduce tobacco smoking in cannabis users. Addiction. 111(2):375. doi: 10.1111/add.13190.
Hindocha C. Freeman T.P. Ferris J.A. Lynskey M.T. Winstock A.R. (2016). No Smoke without tobacco: A global overview of cannabis and tobacco routes of administration and their association with intention to quit. Frontiers in Psychiatry. 7:104. doi: 10.3389/fpsyt.2016.00104.
Hines L.A. Morley K.I. Strang J. Agrawal A. Nelson E.C. Statham D. Martin N.G. Lynskey M.T. (2016). Onset of opportunity to use cannabis and progression from opportunity to dependence: Are influences consistent across transitions? Drug and Alcohol Dependence. 160: 57-64. doi: 10.1016/j.drugalcdep.2015.12.032.
Hitchman S. C. Calder R. I. Rooke C. G. McNeill A. D. (2016). Small retailers’ tobacco sales and profit margins in two disadvantaged areas of England. AIMS Public Health. 3(1):110-115. doi: 10.3934/publichealth.2016.1.110.
Hopkinson N. S. Millett C. Glantz S. Arnott D. McNeill A. (2016). UK government should fund media campaigns that promote quitting, not films that promote smoking. Addiction. doi: 10.1111/add.13511. [Epub ahead of print].
Jawad M. Choaie E. Brose L. Dogar O. Grant A. Jenkinson E. McEwen A. Millett C. Shahab L. (2016). Waterpipe tobacco use in the United Kingdom: a cross-sectional study among university students and stop smoking practitioners. PLoS One. 11(1):e0146799. doi: 10.1371/journal.pone.0146799.
Jensen C. Forlini C. Partridge B. Hall W. (2016). Australian university students' coping strategies and use of pharmaceutical stimulants as cognitive enhancers. Frontiers in Psychology. 7:277. doi: 10.3389/fpsyg.2016.00277.
Johnson S. Sheridan Rains L. Marwaha S. Strang J. Craig T. Weaver T. McCrone P. King M. Fowler D. Pilling S. Marston L. Omar R.Z. Craig M. Hinton M. (2016). A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trial. Trials. 17(1):515. doi: 10.1186/s13063-016-1620-x.
Kaar S.J. Ferris J. Waldron J. Devaney M. Ramsey J. Winstock A.R. (2016). Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. Journal of Psychopharmacology. 30(4):395-401. doi: 10.1177/0269881116632375.
Kasza K.A. Hyland A.J. Borland R. McNeill A. Fong G.T. Carpenter M.J. Partos T. Cummings K.M. (2016). Cross-country comparison of smokers' reasons for thinking about quitting over time: findings from the International Tobacco Control Four Country Survey (ITC-4C), 2002-2015. Tobacco Control. doi: 10.1136/tobaccocontrol-2016-053299. [Epub ahead of print].
Kelly A.B. Chan G.C. Weier M. Quinn C. Gullo M.J. Connor J.P. Hall W.D. (2016). Parental supply of alcohol to Australian minors: an analysis of six nationally representative surveys spanning 15 years. BMC Public Health. 16:325. doi: 10.1186/s12889-016-3004-2.
Kesten J.M. Ayres R. Neale J. Clark J. Vickerman P. Hickman M. Redwood S. (2016). Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England. International Journal of Drug Policy. 39:99-108. doi: 10.1016/j.drugpo.2016.09.005.
Keurhorst M. Anderson P. Heinen M. Bendtsen P. Baena B. Brzózka K. Colom J. Deluca P. Drummond C. Kaner E. Kłoda K. Mierzecki A. Newbury-Birch D. Okulicz-Kozaryn K. Palacio-Vieira J. Parkinson K. Reynolds J. Ronda G. Segura L. Słodownik L. Spak F. van Steenkiste B. Wallace P. Wolstenholme A. Wojnar M. Gual A. Laurant M. Wensing M. (2016). Impact of primary healthcare providers' initial role security and therapeutic commitment on implementing brief interventions in managing risky alcohol consumption: a cluster randomised factorial trial. Implementation Science. 11:96. doi: 10.1186/s13012-016-0468-5.
Kidd B. Day E. Strang J. (2016). What matters is more than just the choice of pharmaceutical agent. Addiction. 111(5):779-781. doi: 10.1111/add.13312.
Kimergård A. Deluca P. Hindersson P. Breindahl T. (2016). How resistant to tampering are codeine containing analgesics on the market? Assessing the potential for opioid extraction. Pain and Therapy. doi: 10.1007/s40122-016-0053-2. [Epub ahead of print].
Kimergård A. Breindahl T. Hindersson P. Deluca P. (2016). Tampering of opioid analgesics: a serious challenge for public health? Addiction. doi: 10.1111/add.13436. [Epub ahead of print].
Kolliakou A. Ball M. Derczynski L. Chandran D. Gkotsis G. Deluca P. Jackson R. Shetty H. Stewart R. (2016). Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records. European Psychiatry. 38:15-21. doi: 10.1016/j.eurpsy.2016.05.006.
Kouimtsidis C. Stahl D. West R. Drummond C. (2016). Path analysis of cognitive behavioral models in smoking: what is the relationship between concepts involved? Journal of Substance Use. 21(5):553-557. doi: 10.3109/14659891.2015.1093559.
Kristjansson S. McCutcheon V.V. Agrawal A. Lynskey M.T. Conroy E. Statham D.J. Madden P.A. Henders A.K. Todorov A.A. Bucholz K.K. Degenhardt L. Martin N.G. Heath A.C. Nelson E.C. (2016). The variance shared across forms of childhood trauma is strongly associated with liability for psychiatric and substance use disorders. Brain and Behavior. 6(2):e00432. doi: 10.1002/brb3.432.
Kruse G.R. Rigotti N.A. Raw M. McNeill A. Murray R. Pine-Abata H. Bitton A. McEwen A. (2016). Tobacco Dependence Treatment Training Programs: An International Survey. Nicotine and Tobacco Research. 18(5):1012-1018. doi: 10.1093/ntr/ntv142.
Kuipers M.A. Beard E. Hitchman S.C. Brown J. Stronks K. Kunst A.E. McNeill A. West R. (2016). Impact on smoking of England's 2012 partial tobacco point of sale display ban: a repeated cross-sectional national study. Tobacco Control. doi: 10.1136/tobaccocontrol-2015-052724. [Epub ahead of print].
Lader M. Kyriacou A. (2016). Withdrawing benzodiazepines in patients with anxiety disorders. Current Psychiatry Reports. 18(1):8. doi: 10.1007/s11920-015-0642-5.
Lai F.Y. O'Brien J. Bruno R. Hall W. Prichard J. Kirkbride P. Gartner C. Thai P. Carter S. Lloyd B. Burns L. Mueller J. (2016). Spatial variations in the consumption of illicit stimulant drugs across Australia: A nationwide application of wastewater-based epidemiology. Science of the Total Environment. doi: 10.1016/j.scitotenv.2016.05.207. [Epub ahead of print].
Lai F.Y. O'Brien J.W. Thai P.K. Hall W. Chan G. Bruno R. Ort C. Prichard J. Carter S. Anuj S. Kirkbride K.P. Gartner C. Humphries M. Mueller J.F. (2016). Cocaine. MDMA and methamphetamine residues in wastewater: Consumption trends (2009-2015) in South East Queensland. Australia. Science of the Total Environment. doi: 10.1016/j.scitotenv.2016.05.181. [Epub ahead of print].
Lappin J.M. Heslin M. Jones P.B. Doody G.A. Reininghaus U.A. Demjaha A. Croudace T. Jamieson-Craig T. Donoghue K. Lomas B. Fearon P. Murray R.M. Dazzan P. Morgan C. (2016). Outcomes following first-episode psychosis - Why we should intervene early in all ages, not only in youth. Australian and New Zealand Journal of Psychiatry. 50(11):1055-1063. doi: 10.1177/0004867416673454.
Larance B. Campbell G. Peacock A. Nielsen S. Bruno R. Hall W. Lintzeris N. Cohen M. Degenhardt L. (2016). Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy. Drug and Alcohol Dependence. 162:79-87. doi: 10.1016/j.drugalcdep.2016.02.048.
Lee Y.C. Yang H.J. Chen V.C. Lee W.T. Teng M.J. Lin C.H. Gossop M. (2016). Meta-analysis of quality of life in children and adolescents with ADHD: By both parent proxy-report and child self-report using PedsQL™. Research in Developmental Disabilities. 51-52:160-172. doi: 10.1016/j.ridd.2015.11.009.
Lewer D. Beard E. Meier P. Boniface S. Kaner E (2016). Unravelling the alcohol harm paradox: a population-based study of social gradients across very heavy drinking thresholds. BMC Public Health. 16:599. doi: 10.1186/s12889-016-3265-9.
Ii S. Ryan L. Neale J. (2016). Diet and nutrient intake of people receiving opioid agonist treatment (OAT): implications for recovery. Drugs and Alcohol Today. 16(1):59-71. doi: 10.1108/DAT-08-2015-0047.
Lingford-Hughes A. Myers J. Watson B. Reid A.G. Kalk N. Feeney A. Hammers A. Riano-Barros D.A. McGinnity C.J. Taylor L.G. Rosso L. Brooks D.J. Turkheimer F. Nutt D.J. (2016). Using [(11) C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism. Neuroimage. 132:1-7. doi: 10.1016/j.neuroimage.2016.02.005.
Lorencatto F. West R. Bruguera C. Brose L.S. Michie S. (2016). Assessing the quality of goal setting in behavioural support for smoking cessation and its association with outcomes. Annals of Behavioral Medicine. 50(2):310-318. doi: 10.1007/s12160-015-9755-7.
Lynskey M. Hall W. (2016). Cannabis use and cannabis use disorders. Lancet Psychiatry. 3(10):911-912. doi: 10.1016/S2215-0366(16)30270-X
Lynskey M.T. Hindocha C. Freeman T.P. (2016). Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use. Addiction. doi: 10.1111/add.13390. [Epub ahead of print].
Marlow S. L. (2016). Transfixed at the Big Top. Psychologist. 30 Jan 2016.
Marsh J. McNeill A. Lewis S. Coleman T. Bains M. Larwood A. Purdy J. Jones L.L. (2016). Protecting children from secondhand smoke: a mixed-methods feasibility study of a novel smoke-free home intervention. Pilot Feasibility Studies. 12 (2):53. doi: 10.1186/s40814-016-0094-7.
McBride O. Cheng H.G. Slade T. Lynskey M.T. (2016). The role of specific alcohol-related problems in predicting depressive experiences in a cross-sectional national household survey. Alcohol and Alcoholism. doi: 10.1093/alcalc/agw010. [Epub ahead of print].
McDonald R. Strang J. (2016). Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 111(7):1177-1187. doi: 10.1111/add.13326.
McNeill A. (2016). Should clinicians recommend e-cigarettes to their patients who smoke? Yes. Annals of Family Medicine. 14(4):300-301. doi: 10.1370/afm.1962.
McNeill A. Bauld L. Birken M. Hammond D. Moodie C. Stead M. Hitchman S. Hartmann-Boyce J. (2016). Tobacco packaging design for preventing tobacco uptake. Cochrane Database of Systematic Reviews. 2016. 2. CD011245. *Protocol withdrawn as merged and included within protocol/review: 'Tobacco packaging design for reducing tobacco use' doi: 10.1002/14651858.CD011244.pub2.
McVeigh J. Kimergård A. Bates G. Hope V.D. Ncube F. (2016). Harm reduction interventions should encompass people who inject image and performance enhancing drugs. BMJ. 353:i1889. doi: 10.1136/bmj.i1889.
Meier M.H. Hall W. Caspi A. Belsky D.W. Cerdá M. Harrington H.L. Houts R. Poulton R. Moffitt T.E. (2016). Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. Psychological Medicine. 46(4):877-889. doi: 10.1017/S0033291715002482.
Meurk C. Morphett K. Carter A. Weier M. Lucke J. Hall W. (2016). Scepticism and hope in a complex predicament: People with addictions deliberate about neuroscience. International Journal of Drug Policy. 32:34-43. doi: 10.1016/j.drugpo.2016.03.004.
Middleton A. Morley K.I. Bragin E. Firth H.V. Hurles M.E. Wright C.F. Parker M. DDD study (2016). Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research. European Journal of Human Genetics. 24(1):21-29. doi: 10.1038/ejhg.2015.58.
Milward J. Khadjesari Z. Fincham-Campbell S. Deluca P. Watson R. Drummond C. (2016). User preferences for content, features, and style for an app to reduce harmful drinking in young adults: analysis of user feedback in app stores and focus group interviews. JMIR MHealth and UHealth. 4(2):e47. doi: 10.2196/mhealth.5242.
Murray R.M. Quigley H. Quattrone D. Englund A. Di Forti M. (2016). Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry. 15(3):195-204. doi: 10.1002/wps.20341.
Myers C.E. Rego J. Haber P. Morley K. Beck K.D. Hogarth L. Moustafa A.A. (2016). Learning and generalization from reward and punishment in opioid addiction. Behavioural Brain Research. 317:122-131. doi: 10.1016/j.bbr.2016.09.033.
Nagelhout G.E. Willemsen M.C. de Vries H. Mons U. Hitchman S.C. Kunst A.E. Guignard R. Siahpush M. Yong H.H.; van den Putte B. Fong G.T. Thrasher J.F. (2016). Educational differences in the impact of pictorial cigarette warning labels on smokers: findings from the International Tobacco Control (ITC) Europe surveys. Tobacco Control. 25(3):325-332. doi: 10.1136/tobaccocontrol-2014-051971.
Neale J. (2016). Iterative categorisation (IC): a systematic technique for analysing qualitative data. Addiction. 111(6):1096–1106. doi: 10.1111/add.13314.
Neale J. Brown C. (2016). 'We are always in some form of contact': Friendships among homeless drug and alcohol users living in hostels. Health and Social Care in the Community. 24(5):557-566. doi: 10.1111/hsc.12215.
Neale J. Bradford J. Strang J. (2016). Development of a proto-typology of opiate overdose onset. Addiction. doi: 10.1111/add.13589. [Epub ahead of print].
Neale J. Parkman T. Day E. Drummond C. (2016). Socio-demographic characteristics and stereotyping of people who frequently attend Accident and Emergency Departments for alcohol-related reasons: Qualitative study. Drugs: Education, Prevention and Policy doi: 10.1080/09687637.2016.1185091. [Epub ahead of print].
Neale J. Tompkins C.N. Strang J. (2016). Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment. Addiction. 111(4):665-674. doi: 10.1111/add.13212.
Neale J. Panebianco D. Finch E. Marsden J. Mitcheson L. Rose D. Strang J. Wykes T. (2016). Emerging consensus on measuring addiction recovery: findings from a multi-stakeholder consultation exercise. Drugs: Education, Prevention and Policy. 23(1): 31-40. doi: 10.3109/09687637.2015.1100587.
Neale J. Vitoratou S. Finch E. Lennon P. Mitcheson L. Panebianco D. Rose D. Strang J. Wykes T. Marsden J. (2016). Development and validation of ‘SURE’: a patient reported outcome measure for recovery from drug and alcohol dependence. Drug and Alcohol Dependence.165 (1):159 – 167. doi: 10.1016/j.drugalcdep.2016.06.006.
Nelson E.C. Agrawal A. Heath A.C. Bogdan R. Sherva R. Zhang B. Al-Hasani R. Bruchas M.R. Chou Y.L. Demers C.H. Carey C.E. Conley E.D. Fakira A.K. Farrer L.A. Goate A. Gordon S. Henders A.K. Hesselbrock V. Kapoor M. Lynskey M.T. Madden P.A. Moron J.A. Rice J.P. Saccone N.L. Schwab S.G. Shand F.L. Todorov A.A. Wallace L. Wang T. Wray N.R. Zhou X. Degenhardt L. Martin N.G. Hariri A.R. Kranzler H.R. Gelernter J. Bierut L.J. Clark D.J. Montgomery G.W. (2016). Evidence of CNIH3 involvement in opioid dependence. Molecular Psychiatry. 21(5):608-614. doi: 10.1038/mp.2015.102.
Nettleton S. Meadows R. Neale J. (2016). Disturbing sleep and sleepfulness during recovery from substance dependence in residential rehabilitation settings. Sociology of Health and Illness. doi: 10.1111/1467-9566.12528. [Epub ahead of print].
Ng Fat L. Scholes S. Boniface S. Mindell J. Stewart-Brown S. (2016). Evaluating and establishing national norms for mental wellbeing using the short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS): findings from the Health Survey for England. Quality of Life Research. Nov 16. [Epub ahead of print] doi: 10.1007/s11136-016-1454-8.
Nutt R. Gilchrist G. Baldacchino A. Marsa Sambola F. [in press]. Staff regard towards working with patients who have co-morbid depression and substance misuse disorders: an exploratory study. Heroin Addiction and Related Clinical Problems.
Palamar J.J. Barratt M.J. Ferris J.A. Winstock A.R. (2016). Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States. American Journal of Addiction. 25(5):400-407. doi: 10.1111/ajad.12403.
Parmar M.K. Strang J. Choo L. Meade A.M. Bird S.M. (2016). Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addiction. doi: 10.1111/add.13668. [Epub ahead of print].
Partos T.R. Cropper S.J. Rawlings D. (2016). You don't see what I see: individual differences in the perception of meaning from visual stimuli. PLoS One 11(3):e0150615. doi: 10.1371/journal.pone.0150615
Patton R. Boniface S. (2016). Prevalence of hazardous drinking among UK 18-35 year olds: the impact of a revision to the AUDIT cut score. Alcohol and Alcoholism. 51(3):281-282. doi: 10.1093/alcalc/agv115.
Peacock A. Degenhardt L. Campbell G. Larance B. Nielsen S. Hall W. Mattick R.P. Bruno R. (2016). A typology of predictive risk factors for non-adherent medication-related behaviors among chronic non-cancer pain patients prescribed opioids: A cohort study. Pain Physician. 19(3):E421-34.
Pierce M. Bird S.M. Hickman M. Marsden J. Dunn G. Jones A. Millar T. (2016). Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction. 111(2):298-308. doi: 10.1111/add.13193.
Ratcliffe K. Chopra B. Day E (2016): Understanding diversion of prescribed opioid agonist medications in Birmingham, UK—prevalence and predictors of diversion. Heroin Addiction and Related Clinical Problems. Heroin Addiction and Related Clinical Problems. 19(1) 27-40. PDF (p27-p40). [Epub ahead of print].
Radcliffe P. Gilchrist G. (2016). ‘‘You can never work with addictions in isolation’’: Addressing intimate partner violence perpetration by men in substance misuse treatment. International Journal of Drug Policy. doi: 10.1016/j.drugpo.2016.03.010. [Epub ahead of print].
Radcliffe P. Tompkins C. (2016). Recovery in addictions policy and practice: meanings and challenges. Drugs and Alcohol Today. 16(1): doi: 10.1108/DAT-01-2016-0003.
Radcliffe P. Flavia A. Figueiredo W. Gilchrist G. (2016). Accounting for Intimate Partner Violence perpetration. A cross-cultural comparison of English and Brazilian substance misusing men's explanations for perpetrating violence towards their intimate partners. Drug and Alcohol Review. 36(1): 64-71. doi: 10.1111/dar.12450. [Epub ahead of print].
Radcliffe P. Flávia Pires Lucas d'Oliveira A. Lea S. Dos Santos Figueiredo W. Gilchrist G. (2016). Accounting for intimate partner violence perpetration. A cross-cultural comparison of English and Brazilian male substance users' explanations. Drug and Alcohol Review. doi: 10.1111/dar.12450. [Epub ahead of print].
Rafia R. Dodd P. J. Brennan A. Meier P. S. Hope V. D. Ncube F. Byford S. Tie H. Metrebian N. Hellier J. Weaver T. Strang J. (2016). An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Addiction. doi: 10.1111/add.13385. [Epub ahead of print].
Ribeiro M. Duailibi S. Frajzinger R. Alonso A.L. Marchetti L. Williams A.V. Strang J. Laranjeira R. (2016). The Brazilian 'Cracolandia' open drug scene and the challenge of implementing a comprehensive and effective drug policy. Addiction. 111(4):571-573. doi: 10.1111/add.13151.
Richmond-Rakerd L.S. Slutske W.S. Lynskey M.T. Agrawal A. Madden P.A. Bucholz K.K. Heath A.C. Statham D.J. Martin N.G. (2016). Age at first use and later substance use disorder: Shared genetic and environmental pathways for nicotine, alcohol, and cannabis. Journal of Abnormal Psychology. doi: 10.1037/abn0000191. [Epub ahead of print].
Roberts E. Eden Evins A. McNeill A. Robson D. (2016). Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction. 111(4):599-612. doi: 10.1111/add.13236.
Robotham D. Wykes T. Rose D. Doughty L. Strange S. Neale J. Hotopf M. (2016). Service user and carer priorities in a Biomedical Research Centre for mental health. Journal of Mental Health. 25(3):185-188. doi: 10.3109/09638237.2016.1167862.
Robson D. Yates M. Craig T.J. Healey A. McNeill A. (2016). Time to smoke: Facilitating smoking breaks in mental health inpatient settings. Nicotine and Tobacco Research. 18(8):1794-1797. doi: 10.1093/ntr/ntw103.
Schwantes-An T.H. Zhang J. Chen L.S. Hartz S.M. Culverhouse R.C. Chen X. Coon H. Frank J. Kamens H.M. Konte B. Kovanen L. Latvala A. Legrand L.N. Maher B.S. Melroy W.E. Nelson E.C. Reid M.W. Robinson J.D. Shen P.H. Yang B.Z. Andrews J.A. Aveyard P. Beltcheva O. Brown S.A. Cannon D.S. Cichon S. Corley R.P. Dahmen N. Degenhardt L. Foroud T. Gaebel W. Giegling I. Glatt S.J. Grucza R.A. Hardin J. Hartmann A.M. Heath A.C. Herms S. Hodgkinson C.A. Hoffmann P. Hops H. Huizinga D. Ising M. Johnson E.O. Johnstone E. Kaneva R.P. Kendler K.S. Kiefer F. Kranzler H.R. Krauter K.S. Levran O. Lucae S. Lynskey M.T. Maier W. Mann K. Martin N.G. Mattheisen M. Montgomery G.W. Müller-Myhsok B. Murphy M.F. Neale M.C. Nikolov M.A. Nishita D. Nöthen M.M. Nurnberger J. Partonen T. Pergadia M.L. Reynolds M. Ridinger M. Rose RJ. Rouvinen-Lagerström N. Scherbaum N. Schmäl C. Soyka M. Stallings M.C. Steffens M. Treutlein J. Tsuang M. Wall T.L. Wodarz N. Yuferov V. Zill P. Bergen A.W. Chen J. Cinciripini P.M. Edenberg H.J. Ehringer M.A. Ferrell R.E. Gelernter J. Goldman D. Hewitt J.K. Hopfer C.J. Iacono W.G. Kaprio J. Kreek M.J. Kremensky I.M. Madden P.A. McGue M. Munafò M.R. Philibert R.A. Rietschel M. Roy A. Rujescu D. Saarikoski S.T. Swan G.E. Todorov A.A. Vanyukov M.M. Weiss R.B. Bierut L.J. Saccone N.L. (2016). Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Behavior Genetics. 46(2):151-169. doi: 10.1007/s10519-015-9737-3.
Shahab L. Dobbie F. Hiscock R. McNeill A. Bauld L. (2016). Prevalence and impact of long-term use of nicotine replacement therapy in UK Stop-Smoking Services: findings from the ELONS study. Nicotine and Tobacco Research. doi: 10.1093/ntr/ntw258. [Epub ahead of print].
Sharma R. Gartner C.E. Hall W.D. (2016). The challenge of reducing smoking in people with serious mental illness. Lancet Respiratory Medicine. 4(10):835-844. doi: 10.1016/S2213-2600(16)30228-4.
Sims M. Langley T. Lewis S. Richardson S. Szatkowski L. McNeill A. Gilmore A.B. (2016). Effectiveness of tobacco control television advertisements with different types of emotional content on tobacco use in England, 2004-2010. Tobacco Control. 25 (1): 21-26. doi: 10.1136/tobaccocontrol-2013-051454.
Stepankova L. Kralikova E. Zvolska K. Pankova A. Ovesna P. Blaha M. Brose L.S. (2016). Depression and smoking cessation: Evidence from a smoking cessation clinic with 1-year follow-up. Annals of Behavioral Medicine. doi: 10.1007/s12160-016-9869-6. [Epub ahead of print].
Stockings E. Hall W.D. Lynskey M. Morley K.I. Reavley N. Strang J. Patton G. Degenhardt L. (2016). Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 3(3): 280–296. doi: 10.1016/S2215-0366(16)00002-X.
Strang J. McDonald R. (2016). New approved nasal naloxone welcome, but unlicensed improvised naloxone spray kits remain a concern: proper scientific study must accompany innovation. Addiction. 111(4):590-592. doi: 10.1111/add.13319.
Strang J. McDonald R (eds) (2016). Preventing Opioid Overdose Deaths with Take-home Naloxone. EMCDDA Insights Series Volume 20. Lisbon: EMCDDA. ISBN: 978-92-9168-837-1 doi:10.2810/357062.
Strang J. McDonald R. Tas B. Day E. (2016). Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures? Addiction. 111(4):574-582. doi: 10.1111/add.13209.
Strang J. McDonald R. Alqurshi A. Royall P. Taylor D. Forbes B. (2016). Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal. Drug and Alcohol Dependence. 163:16-23. doi: 10.1016/j.drugalcdep.2016.02.042.
Swift W. Slade T. Carragher N. Coffey C. Degenhardt L. Hall W. Patton G. (2016). Adolescent predictors of a typology of DSM-5 alcohol use disorder symptoms in young adults derived by latent class analysis using data from an Australian cohort study. Journal of Studies on Alcohol and Drugs. 77(5):757-765. doi: 10.15288/jsad.2016.77.757.
Szatkowski L. Taylor J. Taylor A. Lewis S. Britton J. McNeill A. Bauld L. Wu Q. Parrott S. Jones L. Bains M. (2016). Development and evaluation of an intervention providing insight into the tobacco industry to prevent smoking uptake: a mixed-methods study. Public Health Research. 4(9). doi: 10.3310/phr04090.
Taylor J. Taylor A. Lewis S. McNeill A. Britton J. Jones L.L. Bauld L. Parrott S. Wu Q. Szatkowski L. Bains M. (2016). A qualitative evaluation of a novel intervention using insight into tobacco industry tactics to prevent the uptake of smoking in school-aged children. BMC Public Health. 16:539. doi: 10.1186/s12889-016-3205-8.
Thai P.K. Lai F.Y. Bruno R. van Dyken E. Hall W. O'Brien J. Prichard J. Mueller J.F. (2016). Refining the excretion factors of methadone and codeine for wastewater analysis - combining data from pharmacokinetic and wastewater studies. Environment International. 94:307-314. doi: 10.1016/j.envint.2016.05.033.
Thurgood S.L. McNeill A. Clark-Carter D. Brose L.S. (2016). A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine and Tobacco Research. 18(5):993-1001. doi: 10.1093/ntr/ntv127.
Tompkins C.N.E. Neale J. Strang J. S. (2016). Qualitative study of welcome houses: a recent initiative designed to improve retention in therapeutic communities. Addiction Research and Theory. doi.org/10.1080/16066359.2016.1239082. [Epub ahead of print].
van der Heide S. Garcia Calavia P. Hardwick S. Hudson S. Wolff K. Russell D.A. (2016). A competitive enzyme immunoassay for the quantitative detection of cocaine from banknotes and latent fingermarks. Forensic Science International. 250:1-7. doi: 10.1016/j.forsciint.2015.02.008.
Vera J.H. Guo Q. Cole J.H. Boasso A. Greathead L. Kelleher P. Rabiner E.A. Kalk N. Bishop C. Gunn R.N. Matthews P.M. Winston A. (2016). Neuroinflammation in treated HIV-positive individuals: A TSPO PET study. Neurology. 86(15):1425-1432. doi: 10.1212/WNL.0000000000002485.
Vella A.M. Savona Ventura C. Wolff K. (2016). Pregnancy outcomes in substance-misusing pregnant women: A 10-year retrospective study. Journal of Obstetrics and Gynaecology. 36(4):468-472. doi: 10.3109/01443615.2015.1072805.
Venn A. Dickinson A. Murray R. Jones L. Li J. Parrott S. McNeill A. (2016). Effectiveness of a mobile, drop-in stop smoking service in reaching and supporting disadvantaged UK smokers to quit. Tobacco Control. 25(1):33-38. doi: 10.1136/tobaccocontrol-2014-051760.
Venkataraman A. Kalk N. Sewell G. Ritchie C.W. Lingford-Hughes A. (2016). Alcohol and Alzheimer's Disease-does alcohol dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? Alcohol and Alcoholism. doi: 10.1093/alcalc/agw092. [Epub ahead of print].
Wadsworth E. Neale J. McNeill A. Hitchman S.C. (2016). How and why do smokers start using e-cigarettes? Qualitative study of vapers in London, UK. International Journal of Environmental Research and Public Health. 13(7):661. doi: 10.3390/ijerph13070661.
Waite C. Wilcox J. Tomlinson L. Driscoll J. Karim A. Day E. Sharif A. (2016). Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial. BMC Trials 17:417. doi: 10.1186/s13063-016-1543-6. [Epub ahead of print].
Werner K.B. McCutcheon V.V. Challa M. Agrawal A. Lynskey M.T. Conroy E. Statham D.J. Madden P.A. Henders A.K. Todorov A.A. Heath A.C. Degenhardt L. Martin N.G. Bucholz K.K. Nelson E.C. (2016). The association between childhood maltreatment, psychopathology, and adult sexual victimization in men and women: results from three independent samples. Psychological Medicine. 46(3):563-573. doi: 10.1017/S0033291715002056.
Willey H. Eastwood B. Gee I.L. Marsden J. (2016). Is treatment for alcohol use disorder associated with reductions in criminal offending? A national data linkage cohort study in England. Drug and Alcohol Dependence. 161:67-76. doi: 10.1016/j.drugalcdep.2016.01.020.
Winstock A.R. Lawn W. Deluca P. Borschmann R. (2016). Methoxetamine: an early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review. 35(2):212-227. doi: 10.1111/dar.12259.
Wright N.M.J. Allgar V. Tompkins C.N.E. (2016). Associations between injecting illicit drugs into the femoral vein and deep vein thrombosis: A case control study. Drug and Alcohol Review. doi: 10.1111/dar.12359. [Epub ahead of print].
Zhang S. Dissanayaka N.N. Dawson A. O'Sullivan J.D. Mosley P. Hall W. Carter A. (2016). Management of impulse control disorders in Parkinson's disease. International Psychogeriatrics. doi: 10.1002/mds.26099. [Epub ahead of print].
Yong H.H. Borland R. Balmford J. Hitchman S.C. Cummings K.M. Driezen P. Thompson M.E. (2016). Prevalence and correlates of the belief that electronic cigarettes are a lot less harmful than conventional cigarettes under the different regulatory environments of Australia and the United Kingdom. Nicotine and Tobacco Research. doi: 10.1093/ntr/ntw137. [Epub ahead of print].
Yong H.H. Borland R. Cummings K.M. Lindblom E.N. Li L. Bansal-Travers M. O'Connor R.J. Elton-Marshall T. Thrasher J.F. Hammond D. Thompson M.E. Partos T.R. (2016). US smokers' beliefs, experiences and perceptions of different cigarette variants before and after the FSPTCA ban on misleading descriptors such as "Light," "Mild," or "Low". Nicotine and Tobacco Research. doi: 10.1093/ntr/ntw107. [Epub ahead of print].